AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Shareholder Equity 2019–2025
AbCellera Biologics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- AbCellera Biologics Inc. shareholder equity as of December 31, 2025: 966.9M, a 8.44% decrease year-over-year.
- AbCellera Biologics Inc. shareholder equity for 2025 were 966.9M, a 8.44% decrease from 2024.
- AbCellera Biologics Inc. shareholder equity for 2024 were 1.06B, a 8.35% decrease from 2023.
- AbCellera Biologics Inc. shareholder equity for 2023 were 1.15B, a 6.56% decrease from 2022.
- AbCellera Biologics Inc. shareholder equity for 2022 were 1.23B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AbCellera Biologics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $967 |
| 2024 | $1,056 |
| 2023 | $1,152 |
| 2022 | $1,233 |
| 2021 | $1,026 |
| 2020 | $831 |
AbCellera Biologics Inc. Shareholder Equity — FAQ
AbCellera Biologics Inc. (ABCL) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABCL's shareholder equity history?
The chart and table above show AbCellera Biologics Inc.'s shareholder equity by year and by quarter, including the growth rate.